ONYIA JUDE (Chief Scientific Officer) received a stock award from NEUROCRINE BIOSCIENCES INC
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 9/15/2026ACC: 0001894425-26-000020
Officer· Chief Scientific Officer
Since Nov 2021
+1.65K
Net shares
Net buyer
$302.4K
Total sold
0
Open market trades
0B · 0S
2
Total transactions
3.59K acquired · 1.94K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+3.59K
Price / share
—
Trade value
—
% of position
17.1%
9/11/2026
21K→24.58K
Common Stock
Direct
Shares
−1.94K
Price / share
$156.22
Trade value
$302.44K
% of position
7.9%
9/11/2026
24.58K→22.65K
Total
Net shares
+1.65K
Net value
-$302.44K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 9/11/2026 | A · Award | +3.59K | — | — | 17.1% | 21K | 24.58K |
| Common Stock Direct | 9/11/2026 | F · Tax Withholding | −1.94K | $156.22 | $302.44K | 7.9% | 24.58K | 22.65K |
| Total | +1.65K | -$302.44K | ||||||
Derivative Transactions0
No derivative transactions reported